Table: begin end state 1 26 signal peptide 27 28 transmembrane 29 29 signal peptide 30 36 non-cytoplasmic 37 55 transmembrane 56 94 cytoplasmic 95 115 transmembrane 116 120 non-cytoplasmic 121 141 transmembrane 142 162 cytoplasmic 163 186 transmembrane 187 192 non-cytoplasmic 193 212 transmembrane 213 223 cytoplasmic 224 244 transmembrane 245 258 non-cytoplasmic 259 279 transmembrane 280 286 cytoplasmic 287 306 transmembrane 307 327 non-cytoplasmic 328 348 transmembrane 349 367 cytoplasmic 368 388 transmembrane 389 467 non-cytoplasmic 468 487 transmembrane 488 512 cytoplasmic 513 532 transmembrane 533 544 non-cytoplasmic 545 569 transmembrane 570 575 cytoplasmic 576 598 transmembrane 599 646 non-cytoplasmic 647 670 transmembrane 671 688 cytoplasmic
Input: >Pf1N1B4_2771 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2771 MKNNNSLLRHLPWLLLAILGACALGVVALRRGEAINALWIVVAAVAIYLVAYRYYSLFIA NNVMQLDPRRATPAVLNNDGLDYVPTNKHILFGHHFAAIAGAGPLVGPVLAAQMGYLPGT LWLIAGVVLAGAVQDFMVLFMSTRRNGRSLGDMVREEMGRIPGTIALFGCFLIMIIILAV LALIVVKALAESPWGIFTVMATIPIAMFMGIYMRYIRPGRIGEISVIGVALLLGSIWLGG QIAADPVWAKAFSFTGVQITWMLIGYGFVAAVLPVWLILAPRDYLSTFLKIGTIVALAIG ILITMPELKMPALTQFIDGTGPVWKGGLFPFLFITIACGAVSGFHALISSGTTPKLLDNE VNARYIGYGGMLMESFVAIMAMVAASVIEPGVYFAMNSPAAVVGGDVVAVAQAVSNWGFA ITPEALQAVAKDIGETTILARAGGAPTLAVGIAQILHSVLPGENTMAFWYHFAILFEALF ILTAVDAGTRAGRFMLQDLLGSFVPALKRTESWTANLIATAGCVAMWGYLLYQGVIDPLG GINTLWPLFGISNQMLAGIALMLATVVLIKMKRQRYIWVTMLPAVWLLICTTTAGFIKLF DANPAIGFLALAKKYSDALANGQILAPAKSIEQMQHVIYNAYTNATLTVLFLLVVFSILF FALKVGIAAWGKKERSDKESPFQAQPDA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server